Veterinary pharmacovigilance monitors the safety of veterinary medicines, including vaccines, used for the prophylaxis, diagnosis or treatment of disease in animals once they reach the market after authorization. The task of veterinary pharmacovigilance is to ensure:
This can only be achieved if all observed adverse events, either by veterinarian, animal keeper or pet owner, are reported to the national competent authorities or to the marketing authorization holder of the veterinary medicine. The following observations are considered to be adverse events:
All adverse events can be reported to your national competent authority or to Huvepharma using the following email addresses; for adverse events in the EU please email firstname.lastname@example.org, and for the rest of the world please email email@example.com.
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Update your browser to view this website correctly. Update my browser now